tert-Butyl 4-(1H-indazol-3-yl)piperazine-1-carboxylate
≥95%
- Product Code: 149736
CAS:
947498-81-9
| Molecular Weight: | 302.37 g./mol | Molecular Formula: | C₁₆H₂₂N₄O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Used as an intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other bioactive molecules targeting cancer and inflammatory diseases. Its structure supports the construction of complex drug candidates by providing a stable piperazine core functionalized with an indazole moiety, known for its role in enhancing binding affinity to biological targets. Commonly employed in medicinal chemistry for SAR studies and scaffold modification to optimize potency, selectivity, and pharmacokinetic properties.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1g | 10-20 days | ฿43,020.00 |
+
-
|
tert-Butyl 4-(1H-indazol-3-yl)piperazine-1-carboxylate
Used as an intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other bioactive molecules targeting cancer and inflammatory diseases. Its structure supports the construction of complex drug candidates by providing a stable piperazine core functionalized with an indazole moiety, known for its role in enhancing binding affinity to biological targets. Commonly employed in medicinal chemistry for SAR studies and scaffold modification to optimize potency, selectivity, and pharmacokinetic properties.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :